I know next to nothing about oncology, but
- 11% average tumour reduction;
- in 2 weeks;
- at a significantly diluted dosage
- with a proven safety profile in animals (Zolvix)
It's not earth shattering news but it seemingly works (even at a low dose), in a timely manner, and is safe.
A bit harsh to say it's hard to get excited about imho. On the contrary, who isn't keen to see what tumour reduction is achievable with a full dose?
I know next to nothing about oncology, but - 11% average tumour...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.5¢ |
Change
0.005(2.78%) |
Mkt cap ! $89.95M | |||
| Open | High | Low | Value | Volume |
| 18.5¢ | 19.0¢ | 18.5¢ | $111.6K | 601.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 169572 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 613756 | 10 |
View Market Depth
| Last trade - 15.46pm 30/08/2024 (20 minute delay) ? |
| PAA (ASX) Chart |